Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Stomach Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1

Interventions

vactosertib 1pemigatinib 1pembrolizumab 1fludarabine phosphate 1aldesleukin 1Urinalysis 1Trastuzumab 1Standard of Care 1Quality of Life 1Practice Guidelines as Topic 1Patient Reported Outcome Measures 1Palliative Care 1Molecular Diagnostic Techniques 1Interleukin-2 1Immunotherapy 1IL32 protein, human 1Hematologic Tests 1Gemcitabine 1Fentanyl 1Drug Therapy 1Docetaxel 1Cyclophosphamide 1Cisplatin 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Hematologic Tests × Myeloid × Clear all
NCT00580281 2013-10-24

Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors

Memorial Sloan Kettering Cancer Center

Phase NA Completed
33 enrolled
GastrointestinalMyeloidOther hematologic neoplasm

Leukemia, Stomach Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡